ADCT·NYSE·US
ADC Therapeutics
ADC Therapeutics is a commercial-stage oncology biotechnology company focused on developing and commercializing targeted antibody-drug conjugate therapies for blood cancers and solid tumors. Its lead marketed product is ZYNLONTA, which generates substantially all product revenue.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.